Literature DB >> 10986731

Body dysmorphic disorder.

A Allen1, E Hollander.   

Abstract

The understanding of BDD and its treatment has expanded significantly in the past decade as controlled research has followed the leads from case reports and clinical experience. BDD is recognized as a severe, disabling disorder that is more common that had been assumed. Although BDD is still difficult to treat, success has been demonstrated for SRIs and CBT. Much remains to be discovered. To date, little is known about the causes and pathophysiology of BDD. Research that would illuminate these also would increase understanding of its relationship to other disorders, such as OCD, depression, and social phobia, and open up possibilities for prevention and new approaches to treatment. Investigations in brain imaging and genetics are underway. Research in pharmacotherapy and CBT, individually and combined, is needed to refine, extend, and optimize treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10986731     DOI: 10.1016/s0193-953x(05)70184-2

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  3 in total

1.  Pharmacotherapy for body dysmorphic disorder: treatment received and illness severity.

Authors:  Katharine A Phillips; Maria E Pagano; William Menard
Journal:  Ann Clin Psychiatry       Date:  2006 Oct-Dec       Impact factor: 1.567

2.  Screening for Body Dysmorphic Disorder in a Dermatology Outpatient Setting at a Tertiary Care Centre.

Authors:  Fibin Thanveer; Niti Khunger
Journal:  J Cutan Aesthet Surg       Date:  2016 Jul-Sep

3.  Case report of body dysmorphic disorder in a suicidal patient.

Authors:  Yingfeng Zhang; Hongxia Ma; Yanbin Wang
Journal:  Shanghai Arch Psychiatry       Date:  2016-02-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.